Cargando…
Partial nicotinic acetylcholine (α4β2) agonists as promising new medications for smoking cessation
OBJECTIVE: To review the pharmacology, clinical efficacy and safety of partial agonists of α4β2 nicotinic acetylcholine receptor. DATA SOURCES: Primary literature and review articles were obtained via a PUBMED search (1988-August 2006) using the key terms smoking cessation, partial agonist alpha4bet...
Autores principales: | Singh, J., Budhiraja, Salil |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2792622/ https://www.ncbi.nlm.nih.gov/pubmed/20040957 http://dx.doi.org/10.4103/0253-7613.44150 |
Ejemplares similares
-
Nicotine receptor partial agonists for smoking cessation
por: Livingstone-Banks, Jonathan, et al.
Publicado: (2023) -
Nicotine receptor partial agonists for smoking cessation
por: Livingstone-Banks, Jonathan, et al.
Publicado: (2023) -
Targeting the α4β2- and α7-Subtypes of Nicotinic Acetylcholine Receptors for Smoking Cessation Medication Development
por: Ramachandran Nair, Lakshmi, et al.
Publicado: (2019) -
Orthosteric and Allosteric Ligands of Nicotinic Acetylcholine Receptors for Smoking Cessation
por: Mohamed, Tasnim S., et al.
Publicado: (2015) -
Role of nicotine receptor partial agonists in tobacco cessation
por: Maity, Nivedita, et al.
Publicado: (2014)